GlycoMantra was awarded a SBIR Phase 1 grant to investigate NASH fibrosis.
Related Posts
GlycoMantra received Investor Initiative Award from the NCI (NIH).
July 2017 GlycoMantra received Investor Initiative Award from the NCI (NIH). Through this mechanism,…
GlycoMantra received STTR grant from the NCI (NIH)
September 07, 2017 GlycoMantra received STTR grant from the NCI (NIH). With the University of…